Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Other hematologic neoplasm 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 755 Carcinoma, Renal Cell 241 Urinary Bladder Neoplasms 213 Carcinoma, Transitional Cell 117 Breast Neoplasms 102 Kidney Neoplasms 100 Neoplasms 91 Carcinoma, Non-Small-Cell Lung 86 Melanoma 83 Ovarian Neoplasms 82 Colorectal Neoplasms 76 Neoplasm Metastasis 71 Non-Muscle Invasive Bladder Neoplasms 58 Lung Neoplasms 58 Pancreatic Neoplasms 49 Endometrial Neoplasms 46 Sarcoma 45 Stomach Neoplasms 42 Uterine Cervical Neoplasms 41 Carcinoma, Hepatocellular 36 Adenocarcinoma 36 Wilms Tumor 34 Esophageal Neoplasms 33 Triple Negative Breast Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 31 Head and Neck Neoplasms 29 Testicular Neoplasms 26 Metastatic Castration-resistant Prostate Cancer 25 Disease 24 Colonic Neoplasms 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × Genitourinary × 90 days × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡